A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Study Identifier
APMA-001211
CT.gov Identifier
NCT01594970
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • Bimatoprost 0.01%
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Elevated IOP due to either primary open-angle glaucoma or ocular hypertension
    Exclusion Criteria:
    * None

    Protocol Summary

    This study will evaluate the safety and efficacy of bimatoprost 0.01% in subjects with elevated intraocular pressure (IOP) due to primary open-angle glaucoma (POAG) or ocular hypertension (OH).

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable